UnitedHealth's challenges are manageable, leadership changes boost confidence, and long-term growth shows promise with 15% ...

The company has said in regulatory filings that investigations, audits and reviews by a dozen different government agencies ...

Ken Cohen, a physician and Optum’s executive director of translational research, said Thursday at a conference organized by ...

UnitedHealth is almost as oversold as during the Great Financial Crisis, with its monthly RSI sitting at 33. Find out why UNH ...

UNH has lost more than $200 billion in market value in the last six months. The company’s old CEO sees a fix. Investors ...

Stephen Hemsley hasn't been CEO at UnitedHealth Group in nearly a decade yet he's never really left. Since that day, the company's stock has fallen from $610 a share to $308 on Tuesday, an ...

Investors punished UnitedHealth Group’ s stock further Thursday following a Wall Street Journal report that the U.S. Department of Justice has launched a criminal fraud investigation of Medicare ...

UnitedHealth Group just got a financial flu shot from Raymond James, who slashed earnings estimates and questioned recent ...

CEO Andrew Witty this week has sent shockwaves through an already tumultuous healthcare sector. Investors in UNH stock have ...

UnitedHealth (UNH) has experienced significant volatility, with its stock down approximately 55% from its 52-week high. Once ...

The common theme at the maker of Wegovy and at UnitedHealth may be investors' sudden awareness of cost-cutting pressure.

Shares of UnitedHealth Group tumbled more than 15% in morning trade on Thursday after a report said that the Justice Department is investigating the health insurer for potential fraud ...